Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis - Test2 - elhamkhani - TriplyDB

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis

http://www.wikidata.org/entity/Q34585467

about

Newer antibacterials in therapy and clinical trials Development and Validation of a RP-HPLC Method for Estimation of Prulifloxacin in Tablet Dosage Form.

P2860

Q34488329-55A9B94A-12F4-4371-B82A-F46C02AE3EDF Q36181560-98E46F02-D9BC-4CC8-8B8B-5E5AC97E4B8B

P2860

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis

http://www.wikidata.org/entity/Q34585467

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@ast

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@en

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@nl

type

label

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@ast

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@en

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@nl

prefLabel

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@ast

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@en

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@nl

P1433

Q34585467-67676C37-2FB9-4DDB-B092-EE9F106A7F25

P1476

Q34585467-544731EB-21B8-4FBB-A323-86E6A2A35A4D

P2093

Q34585467-359CEC2E-9FF7-4824-8C5B-563BFD526F43

Q34585467-6D40EF34-2FA7-400C-BDF5-58D75241A749

Q34585467-E08177A0-059B-4E85-A71A-93247A9E64B3

P2860

Q34585467-03D08E08-09B6-4828-B435-A59044F07A06

Q34585467-2958EB0A-864F-4893-9206-7B4A83F1EE1C

Q34585467-466F7856-BA25-47A4-8A20-BB6B9D684E9F

Q34585467-4FDD6378-5314-4A0C-A813-9049D068C907

Q34585467-5D7E719C-DB2F-4929-87ED-C1398720AF7D

Q34585467-68A8163A-217B-4C59-9A96-1CC6F1273B6E

Q34585467-6FF68EE4-28A1-4308-A3EA-57A02631A2E8

Q34585467-726AAFFB-4AB9-45C6-8276-A5C8A4D4FA08

Q34585467-7751634E-4B77-4FEA-8E0C-D8746D9E4249

Q34585467-7A23C5BD-7233-4BAD-899B-71B958EFA0F1

P304

Q34585467-F2ACF46F-3437-4DDD-B962-C27ACE6D08D4

P31

Q34585467-309B33C2-7C7D-43E5-8AFB-4E2DA43B034D

Q34585467-958E6A37-55E5-41DC-B46C-B6FECEFA45BB

P356

Q34585467-FB41D358-9E4C-4E19-A282-EB9AEA9EB585

P407

Q34585467-B22B141A-F4F0-43ED-A5B1-567BCF9583C7

P433

Q34585467-080DC71C-B720-4370-A446-A8D979CBD695

P478

Q34585467-84C8BEDD-A7CB-4186-82B7-752AB9E9AD98

P50

Q34585467-26C8EE8F-4AE0-4E12-A779-676ACA353379

Q34585467-36436346-0C4E-4DFB-8C6A-0ACC2C0D9641

Q34585467-EAC4F8C3-58E0-4AC4-A63E-DE3E2561C5E1

P577

Q34585467-8C474444-16E7-4D14-B5D3-8E9E5706F86E

P5875

Q34585467-797D4095-2EBB-409F-9078-36195F34B291

P698

Q34585467-E73B75C1-48CA-4D19-B3FC-8058304AB65F

P921

Q34585467-1070D57D-155F-4C8C-88B5-8DC83DCD7036

Q34585467-54616497-DB74-4B3F-B500-B278E9AD95C6

Q34585467-F04872AA-F4D9-4A60-A40D-DE48606243F2

P932

Q34585467-40C4B406-A4DE-4B67-990E-533E61A87BF0

P356

COPD.2007.2.1.27

P1433

International Journal of Chronic Obstructive Pulmonary Disease

P1476

Prulifloxacin: a brief review ...... erbation of chronic bronchitis

@en

P2093

Luigi Allegra

http://www.w3.org/2001/XMLSchema#string

Paolo Tarsia

http://www.w3.org/2001/XMLSchema#string

Stefano Centanni

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious etiology of acute exacerbations of chronic bronchitis.

In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.

Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Pharmacokinetics and tolerability of prulifloxacin after single oral administration.

Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.

Prulifloxacin: a new antibacterial fluoroquinolone.

In vivo evaluation of NM441, a new thiazeto-quinoline derivative.

Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.

Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections.

P304

27-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.2007.2.1.27

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Blasi

Stefano Aliberti

Pierachille Santus

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5803949

http://www.w3.org/2001/XMLSchema#string

P698

18044063

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

pharmaceutical preparation

P932

2692114

http://www.w3.org/2001/XMLSchema#string